Insider Trading May 27, 2026 03:46 PM

Director Andrew D’Amico Divests Shares of Vicor Corp Amid Company Growth Signals

Analysis reviews recent insider selling by a director alongside positive corporate developments, including raised revenue guidance and favorable analyst revisions.

By Nina Shah VICR

Vicor Corp director Andrew D’Amico sold common stock totaling $162,562 on May 26, 2026. This transaction occurred after Mr. D'Amico had previously acquired shares through the exercise of non-qualified stock options. Separately, Vicor Corporation has reported strong financial performance indicators and positive outlooks, including a significant increase in its second-quarter 2026 revenue guidance to $142 million, supported by a new patent license agreement.

Director Andrew D’Amico Divests Shares of Vicor Corp Amid Company Growth Signals
VICR

Key Points

  • The company's strong performance is supported by a newly secured patent license agreement with an original equipment manufacturer (OEM), providing enhanced product revenues and royalties.
  • Vicor’s financial results for Q1 2026 showed an EPS of $0.44, which significantly beat analyst expectations ($0.37) and saw revenue hit $112.97 million, surpassing forecasts by 3.59%.
  • Analyst sentiment remains highly positive, evidenced by Needham raising its price target to $350 from $260 while maintaining a Buy rating.

Andrew D’Amico, a director at Vicor Corp (NASDAQ:VICR), reported the sale of common stock valued at $162,562 on May 26, 2026. The disposition covered multiple trades and involved a total of 504 shares of common stock, which were sold at prices that ranged between $320.08 and $324.3551.

The structure of the sales was detailed across several transactions. Specifically, one portion comprised 75 shares sold with a weighted average price of $320.08, where individual transaction prices spanned from $320.00 to $320.12. A second segment involved the sale of another 75 shares at a weighted average price of $321.51. Furthermore, a larger block consisting of 303 shares was divested, priced with a weighted average of $323.1056, and exhibiting individual prices between $323.00 and $323.37. The final component consisted of 51 shares sold at a weighted average price of $324.3551, with recorded individual prices falling between $324.21 and $324.50.

These recent sales followed an acquisition phase for Mr. D’Amico. Prior to the divestiture, he had acquired 504 shares of Vicor Corp common stock by exercising non-qualified stock options. This option exercise occurred at a price of $50.00 per share, representing an initial cost basis of $25,200 for those shares.

Following the entirety of these reported transactions, Mr. D’Amico's direct holdings in Vicor Corp common stock are zero shares. However, his commitment to the company remains through 10,016 non-qualified stock options, which have an expiration period of two years from each vesting date.


Aside from the director’s personal trading activity, Vicor Corporation has provided several notable updates regarding its financial health and future outlook. The company recently announced a substantial increase in its revenue guidance for the second quarter of 2026. Management raised expectations significantly, adjusting the forecast from $126 million up to $142 million.

This upward adjustment is explicitly linked to heightened product revenues and royalties generated by a newly secured patent license agreement. This specific agreement involves an original equipment manufacturer receiving a comprehensive license for Vicor’s patented power system technology. The scope of the licensed technology includes crucial components such as power converter topologies and control systems.

Furthermore, historical financial reporting reinforces a positive trajectory. In its first-quarter 2026 earnings report, Vicor achieved an earnings per share (EPS) of $0.44. This figure surpassed the consensus analyst expectations of $0.37 by a margin of 18.92%. Complementing this, revenue for that quarter reached $112.97 million, exceeding established forecasts by 3.59%.

The market reacted strongly to these positive reports. Following the earnings release, Vicor’s stock experienced a noticeable surge in trading activity, which is typically indicative of strong investor confidence and positive sentiment surrounding the company's performance. This bullish momentum was further supported by Needham, which upgraded its assessment of the company by raising its price target for Vicor to $350 from a previous level of $260, while maintaining a Buy rating on the stock. This revision from the firm reflects both the improved revenue guidance and the potential growth anticipated from the new OEM license agreement. These combined developments underscore Vicor’s positive financial momentum and strategic advancements.


Risks

  • The article does not explicitly detail market risks or uncertainties related to the patent license agreement's fulfillment or terms.
  • While strong financial results are reported, future performance remains dependent on realizing the revenue increases projected through the new OEM license and subsequent quarters.
  • The current report focuses heavily on historical data (Q1 2026) and forward guidance (Q2 2026), meaning the realized execution of the increased guidance represents a key uncertainty.

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026